We are live on
!
Find out more
SHCM
Sachem Head Capital Management Portfolio holdings
AUM
$4.15B
1-Year Est. Return
48.05%
This Fund
S&P 500
This Quarter
Est. Return
+7.8%
1 Year Est. Return
+48.05%
3 Year Est. Return
+105.55%
5 Year Est. Return
+99.81%
10 Year Est. Return
+787.49%
AUM
$1.49B
AUM Growth
-$20.4M
(-1.3%)
Cap. Flow
-$112M
Cap. Flow
% of AUM
-7.52%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
2
Reduced
–
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTC
PTC
|
+$88M |
| 2 |
AGN
Allergan plc
AGN
|
+$52.2M |
| 3 |
Air Products & Chemicals
APD
|
+$26.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$125M |
| 2 |
Viatris
VTRS
|
+$115M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
+$37.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 45.83% |
| 2 | Healthcare | 34.09% |
| 3 | Materials | 9.64% |
| 4 | Technology | 6.13% |
| 5 | Communication Services | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDK
1
DELISTED
CDK Global, Inc.
CDK
| $683M | 45.83% |
12,647,333
| – | – |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $296M | 19.86% |
975,000
+175,000
| +22% | +$52.2M |
|
3
Zoetis
ZTS
$31.9B
| $212M | 14.23% |
4,395,000
| – | – |
|
|
4
Air Products & Chemicals
APD
$66.8B
| $144M | 9.64% |
1,135,050
+194,580
| +21% | +$26.5M |
|
|
5
PTC
PTC
$15.7B
| $91.3M | 6.13% |
+2,225,000
| New | +$88M |
|
|
TFCFA
6
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $64.2M | 4.31% |
1,971,762
| – | – |
|
|
7
Bio-Rad Laboratories Class A
BIO
$8.74B
| – | – |
-280,000
| Closed | -$37.9M |
|
|
8
Viatris
VTRS
$20.7B
| – | – |
-1,945,000
| Closed | -$115M |
|
|
SLXP
9
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| – | – |
-725,000
| Closed | -$125M |
|
Similar funds
ZP
GCM
SP
BOK
AP
HIP
BHC
BG
Sachem Head Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Sachem Head Capital Management held 9 positions worth $1.49B, down 1.3% from $1.51B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Sachem Head Capital Management withdrew a net $112M in Q2 2015, closing 3 positions. Its most notable exit was SALIX PHARMACEUTICALS LTD DEL, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 46% of assets, up from 39% a quarter earlier, followed by Healthcare and Materials.
Against the trend, Sachem Head Capital Management opened a new position in PTC worth $91.3M.
- Sachem Head Capital Management's largest Q2 2015 buy was PTC: 2,225,000 shares worth $91.3M.
- Sachem Head Capital Management added most to Allergan plc in Q2 2015, an estimated $52.2M increase.
- Sachem Head Capital Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $125M.
- Sachem Head Capital Management's ten largest holdings make up 100% of its $1.49B portfolio in Q2 2015.
- Sachem Head Capital Management opened 1 new position and closed 3 in Q2 2015.
- Sachem Head Capital Management's portfolio value fell 1.3% quarter-over-quarter to $1.49B.
Based on Sachem Head Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.